ABGENIX, INC.Loan and Security Agreement • April 3rd, 1998 • Abgenix Inc • California
STOCK PURCHASE and TRANSFER-AGREEMENTServices Agreement • May 26th, 1998 • Abgenix Inc • Biological products, (no disgnostic substances) • California
LICENSE AGREEMENTLicense Agreement • January 28th, 2000 • Abgenix Inc • Biological products, (no disgnostic substances) • California
Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT") is made as of November 19, 1999 by and among (i) Abgenix, Inc., a Delaware corporation (the "COMPANY"), (ii) each person listed on EXHIBIT A attached...Registration Rights Agreement • November 26th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances) • California
ABGENIX, INC.Registration Rights Agreement • November 24th, 1998 • Abgenix Inc • Biological products, (no disgnostic substances) • Delaware
RECITALSAbgenix Inc • January 28th, 2000 • Biological products, (no disgnostic substances) • California
UNDERWRITING AGREEMENT February __, 2000 FleetBoston Robertson Stephens Inc. Lehman Brothers Inc. Merrill Lynch, Pierce, Fenner & Smith Incorporated Pacific Growth Equities, Inc. As Representatives of the Several Underwriters c/o FleetBoston Robertson...Underwriting Agreement • February 10th, 2000 • Abgenix Inc • Biological products, (no disgnostic substances) • New York
ACQUISITION AGREEMENT THIS ACQUISITION AGREEMENT (this "Agreement"), dated as of September 25, 2000 (the "Execution Date"), between Abgenix, Inc., a Delaware corporation ("Parent"), Abgenix Canada Corporation, an unlimited liability company organized...Acquisition Agreement • November 13th, 2000 • Abgenix Inc • Biological products, (no disgnostic substances) • British Columbia
1 EXHIBIT 10.21 MASTER LEASE AGREEMENT Lessor: TRANSAMERICA BUSINESS CREDIT CORPORATION RIVERWAY II WEST OFFICE TOWER 9399 WEST HIGGINS ROAD ROSEMONT, ILLINOIS 60018 Lessee: ABGENIX, INC. 324 LAKESIDE DRIVE FOSTER CITY, CALIFORNIA 94404 The lessor...Master Lease Agreement • April 3rd, 1998 • Abgenix Inc • Illinois
1 EXHIBIT 1.1 3,000,000 SHARES(1) ABGENIX, INC. COMMON STOCK UNDERWRITING AGREEMENT , 1999 BANCBOSTON ROBERTSON STEPHENS INC. LEHMAN BROTHERS INC. PACIFIC GROWTH EQUITIES, INC. As Representatives of the several Underwriters c/o BancBoston Robertson...Abgenix Inc • January 27th, 1999 • Biological products, (no disgnostic substances) • California
1 EXHIBIT 10.41 ABGENIX, INC. REGISTRATION RIGHTS AGREEMENT JANUARY 27, 1999 This Agreement is made as of the date first written above by and between ABGENIX, INC., a Delaware corporation having its principal executive office at 7601 Dumbarton Circle,...Registration Rights Agreement • January 27th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances) • California
RECITALS A. XT, CGI, ABX and JT, along with GenPharm International, Inc. ("GPI"), are entering into that certain Release and Settlement Agreement (the "Settlement Agreement"), dated March 26, 1997, and pursuant thereto that certain Cross License...Agreement • April 3rd, 1998 • Abgenix Inc • California
ABGENIX, INC. andSupport Agreement • November 13th, 2000 • Abgenix Inc • Biological products, (no disgnostic substances) • British Columbia
STOCK PURCHASE AGREEMENT Abgenix, Inc. 7601 Dumbarton Circle Fremont, CA 94555 Cell Genesys, Inc. 342 Lakeside Drive Foster City, CA 94404 Ladies & Gentlemen: The undersigned, _________________________________(the "Investor"), hereby confirms its...Stock Purchase Agreement • November 13th, 2000 • Abgenix Inc • Biological products, (no disgnostic substances) • Delaware
STOCK PURCHASE and TRANSFER-AGREEMENTAgreement • April 3rd, 1998 • Abgenix Inc • California
1 EXHIBIT 10.8E CONFIDENTIAL TREATMENT REQUESTED BY ABGENIX, INC. AMENDMENT NO. 5 TO COLLABORATION AGREEMENT This Amendment to Collaboration Agreement (the "Amendment"), effective as of November __, 1997, (the "Amendment Effective Date"), is made by...Collaboration Agreement • April 3rd, 1998 • Abgenix Inc • California
RECITALSLicense Agreement • May 26th, 1998 • Abgenix Inc • Biological products, (no disgnostic substances) • California
ABGENIX, INC.Indemnification Agreement • April 3rd, 1998 • Abgenix Inc • Delaware
ABGENIX, INC. ANDRights Agreement • November 30th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances) • Delaware
AMENDMENT #2 TO GOVERNANCE AGREEMENTGovernance Agreement • April 3rd, 1998 • Abgenix Inc
ABGENIX, INC. ANDRights Agreement • June 15th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances) • Delaware
RECITALSStockholder Rights Agreement • April 3rd, 1998 • Abgenix Inc • California
ABGENIX, INC. andTrust Agreement • November 13th, 2000 • Abgenix Inc • Biological products, (no disgnostic substances) • British Columbia
RECITALSLicense and Option Agreement • June 30th, 1998 • Abgenix Inc • Biological products, (no disgnostic substances) • California
1 Exhibit 10.29B AMENDMENT NO. 3 TO COLLABORATIVE RESEARCH AGREEMENT This Amendment No. 3 to the Collaborative Research Agreement (the "Amendment No. 3"), effective as of February 12, 1999 (the "Amendment No. 3 Effective Date"), is made by and between...Collaborative Research Agreement • February 25th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances)
RESEARCH COLLABORATION AGREEMENT [*]Research Collaboration Agreement • January 27th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances) • Delaware
ABGENIX, INC. 31/2% Convertible Subordinated Notes Due 2007 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 15th, 2002 • Abgenix Inc • Biological products, (no disgnostic substances) • New York
Abgenix, Inc., a Delaware corporation (the "Company") proposes to issue and sell to Credit Suisse First Boston Corporation, Banc of America Securities LLC and Robertson Stephens, Inc. (collectively, the "Initial Purchasers"), upon the terms set forth in a purchase agreement dated as of February 27, 2002 (the "Purchase Agreement"), $200,000,000 aggregate principal amount (plus up to an additional $50,000,000 principal amount) of its 31/2% Convertible Subordinated Notes due 2007 (the "Initial Securities"). The Initial Securities will be convertible into shares of common stock, par value $0.0001 per share, of the Company (the "Common Stock") at the conversion price set forth in the Offering Circular dated February 27, 2002 (the "Offering Circular"). The Initial Securities will be issued pursuant to an Indenture, dated as of the date hereof (the "Indenture"), between the Company and State Street Bank and Trust Company of California, N.A., as trustee (the "Trustee"). As an inducement to the
ABGENIX, INC.Registration Rights Agreement • December 22nd, 2004 • Abgenix Inc • Biological products, (no disgnostic substances) • New York
Abgenix, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 1.75% Convertible Senior Notes due 2011 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
RECITALSProduct License Agreement • June 30th, 1998 • Abgenix Inc • Biological products, (no disgnostic substances) • California
ABGENIX, INC. COMMON STOCKAbgenix Inc • May 20th, 1998 • Biological products, (no disgnostic substances) • California
RECITALSLicense Agreement • May 26th, 1998 • Abgenix Inc • Biological products, (no disgnostic substances) • California
ABGENIX, INC. and MELLON INVESTOR SERVICES LLC, Rights Agent Amended and Restated Preferred Shares Rights Agreement Dated as of May 9, 2002Preferred Shares Rights Agreement • May 14th, 2002 • Abgenix Inc • Biological products, (no disgnostic substances) • Delaware
This Agreement, dated as of May 9, 2002, is between ABGENIX, INC., a Delaware corporation (the "Company"), and MELLON INVESTOR SERVICES LLC, a New Jersey limited liability company (the "Rights Agent"). This Agreement amends and restates the Preferred Shares Rights Agreement between the Company and the Rights Agent dated June 14, 1999 and previously amended as of November 19, 1999.
RECITALSResearch License and Option Agreement • January 15th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances) • California
SCHERING-PLOUGH RESEARCH INSTITUTECollaborative Research Agreement • June 30th, 1998 • Abgenix Inc • Biological products, (no disgnostic substances) • California
RECITALSProduct License Agreement • May 26th, 1998 • Abgenix Inc • Biological products, (no disgnostic substances) • California
